Semaglutide shows promise in treating chronic skin condition in obese patients
A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.
25 Sep 01:27 · News-Medical